GSI 25 (Vemlidy 25 mg)
Generic Name: tenofovir alafenamide
Pill imprint GSI 25 has been identified as Vemlidy 25 mg.
Vemlidy is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Vemlidy 25 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- tenofovir alafenamide
- GSI 25
- 25 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- CSA Schedule:
- U - Unknown
- Gilead Sciences, Inc.
More about Vemlidy (tenofovir alafenamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.